KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Cash & Equivalents (2016 - 2025)

Insulet (PODD) has disclosed Cash & Equivalents for 16 consecutive years, with $757.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 16.09% year-over-year to $757.4 million, compared with a TTM value of $757.4 million through Sep 2025, down 16.09%, and an annual FY2024 reading of $953.4 million, up 35.39% over the prior year.
  • Cash & Equivalents was $757.4 million for Q3 2025 at Insulet, down from $1.1 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.3 billion in Q1 2025 and bottomed at $620.7 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $810.5 million, with a median of $757.4 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents soared 307.5% in 2021, then fell 17.08% in 2022.
  • Year by year, Cash & Equivalents stood at $791.6 million in 2021, then fell by 14.77% to $674.7 million in 2022, then increased by 4.37% to $704.2 million in 2023, then soared by 35.39% to $953.4 million in 2024, then decreased by 20.56% to $757.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for PODD at $757.4 million in Q3 2025, $1.1 billion in Q2 2025, and $1.3 billion in Q1 2025.